The United States market is driven by robust federal bio-preferred procurement programs, significant private investments in synthetic biology startups, and strong consumer preference for bio-based consumer goods. U.S. chemical conglomerates and agricultural processing leaders prioritize sustainable domestic supply chains, generating consistent, high-volume demand for platform biochemicals and...